{"schema_version":"secwatch.filing_event.v1","accession":"0001854270-25-000077","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2025-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.378065+00:00","generated_at":"2026-05-18T05:49:29.109808+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Senti Bio appoints Bryan Baum to Board of Directors","bullets":["Bryan Baum, co-founder and managing partner of K5 Global, appointed to board effective July 18, 2025.","Baum received initial option award for 43,900 shares vesting monthly over three years; annual cash retainer $35,000.","Board size increased from seven to eight members; Baum fills new seat as Class II director until 2027 annual meeting.","Baum's portfolio includes SpaceX, xAI, Anduril, OpenAI; previously sold companies Blue Vision Labs, Parrot, Operam."],"urls":{"canonical":"https://secwatch.observer/filing/0001854270-25-000077","json":"https://secwatch.observer/filing/0001854270-25-000077.json","markdown":"https://secwatch.observer/filing/0001854270-25-000077.md","text":"https://secwatch.observer/filing/0001854270-25-000077.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000077/0001854270-25-000077-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000077/snti-20250718.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:49:29.109808+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}